Managing Pancreatic Cancer

Tumour Profiling

Tumour profiling is often recommended for patients with pancreatic cancer whose cancer has spread beyond the pancreas. It tells you about the biology of your specific tumour.

Understanding the Test

What is tumour profiling?

Tumour profiling — also called biomarker testing or genomic testing — is the analysis of tumour tissue to understand the specific genetic and molecular characteristics of your cancer.

A tissue sample is collected through a biopsy or surgery and then analysed. It can show changes in the tumour's genes or proteins. Results may influence treatment decisions.

Tumour profiling is not currently available for all patients in Ireland. Access should be discussed with your oncologist.

Key terms explained

Tumour Profiling
Testing of tumour tissue to understand the biology of your specific tumour.
Biomarker Testing
Another name for tumour profiling — looks for specific biological markers in the tumour.
Genomic Testing
Analysis of the genes within the tumour to identify mutations that may guide treatment.
Germline Mutation
An inherited genetic change present in all cells of the body (see Genetic Testing).
Somatic Mutation
A genetic change that occurs only in the tumour cells, not inherited.

The Process

How tumour profiling works

01

Tissue sample collected

A tissue sample is collected through a biopsy or surgery. This is the same sample that may already have been taken as part of your diagnosis.

02

Laboratory analysis

The sample is sent to a specialist laboratory where it is analysed for changes in the tumour's genes or proteins.

03

Results reviewed

Your oncologist reviews the results with you. The findings tell you about the biology of your specific tumour.

04

Treatment decisions informed

Results may influence treatment decisions, potentially identifying targeted therapies or clinical trials that could be beneficial.

Access in Ireland

Availability and next steps

Not yet available to all patients in Ireland

Tumour profiling is not currently available for all patients in Ireland. Access should be discussed with your oncologist, who can advise on whether it is appropriate for your situation and how to access it.

If you believe tumour profiling may be relevant to your care, raise it with your oncologist or a member of your treating team. They can advise on eligibility and any referral pathways that may be available.

You can also contact our support team, who can help you understand your options and prepare questions for your next appointment.

You don't have to face this alone

Our support team is here for patients and families at every stage. Reach out whenever you are ready.